image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

SIGN UP NOW
Updates

Craneware

September 2013

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • CRW
  • Price:
  • 390p
Craneware, the supplier of billing and auditing software to US hospitals, has stated that revenues will be below expectations for the current year and in a range of US$41m-US$42m with adjusted EBITDA US$11.9m-US$12.6m.  Although it continues to see increased sales activity and conversion of its sales pipeline into revenue in small and medium sized hospitals the bugbear was that it hasn't been able to sign any larger hospital deals. These larger contracts are more complex and harder to predict when they will be closed and management has responded by dedicating extra resources to solve this issue. As Craneware state “fiscal and regulatory pressures on all US hospitals continue to drive interest in its products†so medium ter ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Craneware (November 2012)
Craneware - Second downgrade this year (August 2012)
Craneware (March 2012)
Craneware (November 2011)
Craneware - New contract wins (September 2011)
Craneware - Acquistion raises forecasts (April 2011)
Craneware - Another amazing share price spike (December 2010)
Craneware - Shares spike vertically by over £1 (October 2010)
Craneware (June 2010)
Craneware - Billing software firm enjoying quick-fire growth (February 2010)
Craneware - Billing software firm sees huge US healthcare opportunity (October 2008)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X